Skip to main navigation Skip to search Skip to main content

Prediction of major depressive disorder onset in college students

  • David D. Ebert*
  • , Claudia Buntrock
  • , Philippe Mortier
  • , Randy Auerbach
  • , Kiona K. Weisel
  • , Ronald C. Kessler
  • , Pim Cuijpers
  • , Jennifer G. Green
  • , Glenn Kiekens
  • , Matthew K. Nock
  • , Koen Demyttenaere
  • , Ronny Bruffaerts
  • *Corresponding author for this work

Research output: Contribution to Journal › Article › Academic › peer-review

Abstract

BACKGROUND:
Major depressive disorder (MDD) in college students is associated with substantial burden.
AIMS:
To assess 1-year incidence of MDD among incoming freshmen and predictors of MDD-incidence in a representative sample of students.
METHOD:
Prospective cohort study of first-year college students (baseline: n = 2,519, 1-year follow-up: n = 958) RESULTS: The incidence of MDD within the first year of college was 6.9% (SE = 0.8). The most important individual-level predictors of onset were prior suicide plans and/or attempts (OR = 9.5). The strongest population-level baseline predictors were history of childhood-adolescent trauma, stressful experience in the past 12 months, parental psychopathology, and other 12-month mental disorder. Multivariate cross-validated prediction (cross-validated AUC = 0.73) suggest that 36.1% of incident MDD cases in a replication sample would occur among the 10% of students at highest predicted risk (24.5% predicted incidence in this highest-risk subgroup).
CONCLUSIONS:
Screening at college entrance is a promising strategy to identify students at risk of MDD onset, which may improve the development and deployment of targeted preventive interventions.
Original languageEnglish
Pages (from-to)294-304
Number of pages11
JournalDepression and Anxiety
Volume36
Issue number4
Early online date6 Dec 2018
DOIs
Publication statusPublished - Apr 2019

Bibliographical note

FOCUS ON: DEPRESSION DIVERSITY IN TIME AND PLACE

Funding

The Leuven College Survey was carried out in conjunction with the World Health Organization World Mental Health (WMH) survey initiative and is a part of the World Mental Health International College Student project. The WMH survey is supported by the National Institute of Mental Health (NIMH; R01MH070884), the John D. and Catherine T. MacArthur Foundation, the Pfizer Foundation, the US Public Health Service (R13-MH066849, R01-MH069864, and R01 DA016558), the Fogarty International Center (FIRCA R03-TW006481), the Pan American Health Organization, Eli Lilly and Company, Ortho-McNeil Pharmaceutical, GlaxoSmithKline, and Bristol-Myers Squibb. A complete list of all within-country and cross-national WMH publications can be found at http://www.hcp.med.harvard.edu/wmh/. In Belgium specifically, these activities were supported by the Belgian Fund for Scientific Research (11N0514N/11N0516N/1114717N), the King Baudouin Foundation (2014-J2140150-102905), and Eli Lilly (IIT-H6U-BX-I002). In Germany, the preparation of this paper was funded by BARMER.

FundersFunder number
Pfizer Foundation
Pan American Health Organization
World Health Organization World Mental Health
BARMER
GlaxoSmithKline
John D. and Catherine T. MacArthur Foundation
Ortho-McNeil Pharmaceutical
National Institute of Mental HealthR13MH066849, R01MH069864, R01MH070884
U.S. Public Health ServiceR01 DA016558, R13-MH066849, R01-MH069864
Koning Boudewijnstichting2014-J2140150-102905
Belgian Fund for Scientific Research11N0514N/11N0516N/1114717N
Eli Lilly and CompanyIIT-H6U-BX-I002
Fogarty International CenterR03TW006481

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • depression
    • epidemiology
    • health services
    • mood disorders
    • suicide/self-harm

    Fingerprint

    Dive into the research topics of 'Prediction of major depressive disorder onset in college students'. Together they form a unique fingerprint.

    Cite this